US 11,918,608 B2
Methods of treating exercise-induced pulmonary hemorrhage
Karl Nobert, Middleburg, VA (US)
Assigned to RECELLERATE, INC., Middleburg, VA (US)
Filed by RECELLERATE, INC., Middleburg, VA (US)
Filed on Jan. 14, 2021, as Appl. No. 17/149,431.
Application 17/149,431 is a continuation of application No. 15/329,220, granted, now 10,918,669, previously published as PCT/US2015/042105, filed on Jul. 24, 2015.
Claims priority of provisional application 62/029,310, filed on Jul. 25, 2014.
Prior Publication US 2021/0128633 A1, May 6, 2021
This patent is subject to a terminal disclaimer.
Int. Cl. A61K 35/28 (2015.01); A61K 9/00 (2006.01); A61K 31/137 (2006.01); A61K 31/138 (2006.01); A61K 31/167 (2006.01); A61K 31/198 (2006.01); A61K 31/439 (2006.01); A61K 31/44 (2006.01); A61K 31/4704 (2006.01); A61K 31/519 (2006.01); A61K 31/56 (2006.01); A61K 31/573 (2006.01); A61K 31/58 (2006.01); A61K 31/635 (2006.01); A61K 35/12 (2015.01); A61K 45/06 (2006.01)
CPC A61K 35/28 (2013.01) [A61K 9/0078 (2013.01); A61K 31/137 (2013.01); A61K 31/138 (2013.01); A61K 31/167 (2013.01); A61K 31/198 (2013.01); A61K 31/439 (2013.01); A61K 31/44 (2013.01); A61K 31/4704 (2013.01); A61K 31/519 (2013.01); A61K 31/56 (2013.01); A61K 31/573 (2013.01); A61K 31/58 (2013.01); A61K 31/635 (2013.01); A61K 35/12 (2013.01); A61K 45/06 (2013.01)] 15 Claims
 
1. A method of treating exercise-induced pulmonary hemorrhage in a mammal in need thereof, comprising administering an effective amount of a pharmaceutical composition comprising granuloma fluid, or a composition derived therefrom, to the mammal, wherein the granuloma fluid or composition derived therefrom comprises stem cells in an amount of about 5×104 to about 5×1011 cells.